Infosys Ltd Q1 FY2023 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/46jzgtc5ha8ymifkposm4ifm.pdf

Key Takeaways


Revenue Performance & Demand Environment

Parekh: "We are now seeing pockets, this is not across our whole business. And the way I would look at it is with all of that given our pipeline we have increased our revenue guidance. So the majority of our business is still seeing good demand."

Margin Walk & The Investment Thesis

Roy: "We do not want to leave a five-year demand on the table because of short-term cost pressures and these we can optimize over this year and over the future as well."

Talent, Attrition & The Supply Crunch

Roy: "But at this moment in a way we are on a treadmill and therefore this whole subcon increase is easily one lever which we have available."

Deal Wins & Pipeline

Roy: "Now these are much more longer-term impact decisions, but I think at least the conversations have started in right direction across all the segments and you can hear similar commentary across."

Vertical & Segment Performance

Vertical / SegmentTrendCommentary
Financial Services▲ Strong, with pocketsBroad-based digital demand across customer experience, contact center transformation, and virtual branches; mortgage and lending showing slowness from rising interest rates.
Manufacturing▲ Spectacular growthBroad-based across geographies and sub-verticals, led by large deals; traction in energy, IoT, supply chain, cloud ERP. Margins are lower at deal start but management states no historical correlation that large deals are dilutive over time.
Communications▲ 25%+ growthClients focused on rapid digitization and cybersecurity; enormous potential for digital transformation and cost takeout partnerships.
Retail▲ Growth, with cautionPace of digital transformation and cost breakout work continues to rise, but clients are monitoring the macro situation and some slowing in decision-making is visible.
Energy, Utilities, Resources & Services▲ 25%+ growthPipeline comprises cost takeouts, vendor consolidation, digital transformation, cloud-led transformation, and asset monetization.
Life Sciences▲ ExpandingAnnounced acquisition of BASE Life Sciences in Denmark brings domain expertise in medical, digital marketing, clinical, and regulatory areas; management sees the segment as underweight and a strong future opportunity.
Europe▲ 33.2% growthStrongest geographic performer; Denmark acquisition and Scandinavian expansion signal continued investment.

Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growth14%–16% constant-currency growth for FY23, raised from 13%–15%FY23 full year
Operating margin21%–23% band maintained, expected at the bottom end; improvement from 20% in Q1 must begin immediatelyFY23 full year, with QoQ improvement from Q2 onward
Fresher hiring50,000 freshers for the year, with capacity to increase via off-campus programFY23
Subcontractor rationalizationSubcon costs to flatten and decline from ~11.3% toward historical ~6.5% as own hiring convertsOver the course of FY23
Attrition moderationContinued decline expected as engagement initiatives and fresher intake take effectOngoing through FY23
Senior-level wage hikeJuly hike for middle-to-senior employees will have far less than the 160 bps Q1 impactQ2 FY23

Key Metrics

MetricQ1 FY23
Revenue growth (constant currency)21.4% YoY, 5.5% QoQ
Operating margin20.0%, down 150 bps QoQ; wage hikes, utilization, and subcon costs were headwinds
Net profitDeclined QoQ, directly linked to operating margin decline
EPS growth (INR)4.4% YoY
Revenue growth guidance (FY23, constant currency)14%–16%, raised from 13%–15%
Operating margin guidance (FY23)21%–23%, expected at the lower end
Large-deal TCV\$1.69 bn, 19 deals, 50% net new
Digital revenue share61% of total revenue, grew 37.5% YoY in constant currency
US revenue growth (constant currency)18.4% YoY
Europe revenue growth (constant currency)33.2% YoY
Voluntary attrition (LTM)28.4%, increased marginally
Voluntary attrition (quarterly annualized)Declined 1 ppt sequentially, versus a typical Q1 increase of 3–4 ppt
Utilization (excluding trainees)84.7%, down from 88% in the prior year
Net headcount additionOver 21,000 employees
Free cash flow\$656 mn, 95% conversion of net profits